13F Data
13F filer · CIK 1637359

Omega Fund Management, LLC

Boston, MA · filing since Q4 2014 · last filing Aug 14, 2026
Reported value
$185.7M
+$22.5M vs prior
Positions
10
New / sold out
1 / 1
Added / reduced
0 / 1
Turnover
0.0%
buys $54.1K · sells $18.8M
Top-10 weight
100.0%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewOdyssey Therapeutics Inc.+2,893–+$54.1K

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedBicara Therapeutics Inc.-570,000-23.8%$-16.9M
Sold outReplimune Group-248,672-100.0%$-1.9M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2014: $217.4MQ1 2015: $231.3MQ2 2015: $198.1MQ3 2015: $177.6MQ4 2015: $179.7MQ1 2016: $144.2MQ2 2016: $134.8MQ3 2016: $131.0MQ4 2016: $123.2MQ1 2017: $153.8MQ2 2017: $160.2MQ3 2017: $176.8MQ4 2017: $138.3MQ1 2018: $101.8MQ2 2018: $135.5MQ3 2018: $211.4MQ4 2018: $134.9MQ1 2019: $473.1MQ2 2019: $392.1MQ3 2019: $324.0MQ4 2019: $314.2MQ1 2020: $241.6MQ2 2020: $365.7MQ3 2020: $369.7MQ4 2020: $666.9MQ1 2021: $1.1BQ2 2021: $883.6MQ3 2021: $891.4MQ4 2021: $707.3MQ1 2022: $488.6MQ2 2022: $313.3MQ3 2022: $273.1MQ4 2022: $296.7MQ1 2023: $153.3MQ2 2023: $178.5MQ3 2023: $108.9MQ4 2023: $123.4MQ1 2024: $155.0MQ2 2024: $135.0MQ3 2024: $160.0MQ4 2024: $154.2MQ1 2025: $169.5MQ2 2025: $154.4MQ3 2025: $222.4MQ4 2025: $286.5MQ1 2026: $163.1MQ2 2026: $185.7M
Q4 2014Q2 2026

Holdings · Q2 2026